lobbying_activities: 1258191

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1258191	616bb44d-53f1-45e5-a190-e34c2c1a14be	2A	RED+BLUE STRATEGIES	400693064	EXPRESS SCRIPTS INC.	2012	second_quarter	HCR	Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing, Health Information Technology, and Essential Health Benefits. Reauthorization of the Prescription Drug User Fee Act, specifically issues related to track and trace policies and exclusivity. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes. Proposed OPM-focused policies in the Administration's 2013 Budget related to the utilization of Pharmacy Benefit Managers. S. 3187 - The FDA Safety and Innovation Act - Specifically issues regarding down stream supply chain policies and provisions related to the treatment of controlled substances.	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2012-07-05T11:10:35.127000-04:00